BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 28207973)

  • 1. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
    Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
    Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation.
    Mori Y; Miyamoto T; Nagafuji K; Kamezaki K; Yamamoto A; Saito N; Kato K; Takenaka K; Iwasaki H; Harada N; Abe Y; Teshima T; Akashi K
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1596-602. PubMed ID: 20685258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
    Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
    Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.
    Inazawa N; Hori T; Yamamoto M; Hatakeyama N; Yoto Y; Nojima M; Yasui H; Suzuki N; Shimizu N; Tsutsumi H
    J Med Virol; 2016 Feb; 88(2):319-23. PubMed ID: 26241219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral load and ganciclovir (GCV) concentration in cerebrospinal fluid of patients successfully treated with GCV or valGCV for human herpesvirus 6 encephalitis/myelitis following umbilical cord blood transplantation.
    Morita D; Hirabayashi K; Katsuyama Y; Morokawa H; Motobayashi M; Kurata T; Shigemura T; Tanaka M; Inaba Y; Koike K; Nakazawa Y
    Transpl Infect Dis; 2016 Oct; 18(5):773-776. PubMed ID: 27459097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis.
    Murakami K; Kohashi S; Sakurai M; Kato J; Toyama T; Koda Y; Yamane Y; Hashida R; Abe R; Yamazaki R; Kikuchi T; Shimizu T; Suzuki S; Hasegawa N; Okamoto S; Mori T
    Int J Hematol; 2017 Sep; 106(3):436-440. PubMed ID: 28501929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.
    Tamaki H; Ikegame K; Yoshihara S; Kaida K; Yoshihara K; Inoue T; Kato R; Nakata J; Fujioka T; Soma T; Okada M; Ogawa H
    Transpl Infect Dis; 2019 Jun; 21(3):e13073. PubMed ID: 30875143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelitis associated with human herpes virus 6 (HHV-6) after allogeneic cord blood transplantation.
    Mori T; Mihara A; Yamazaki R; Shimizu T; Aisa Y; Suzuki S; Ikeda Y; Okamoto S
    Scand J Infect Dis; 2007; 39(3):276-8. PubMed ID: 17366067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
    Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
    Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
    Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis.
    Shimazu Y; Kondo T; Ishikawa T; Yamashita K; Takaori-Kondo A
    Transpl Infect Dis; 2013 Apr; 15(2):195-201. PubMed ID: 23331378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
    Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
    J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
    Hill JA; Koo S; Guzman Suarez BB; Ho VT; Cutler C; Koreth J; Armand P; Alyea EP; Baden LR; Antin JH; Soiffer RJ; Marty FM
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1638-48. PubMed ID: 22564265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
    Wang LR; Dong LJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen.
    Yamamoto W; Ogusa E; Matsumoto K; Maruta A; Ishigatsubo Y; Kanamori H
    Clin Transplant; 2014 May; 28(5):540-5. PubMed ID: 24579822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
    Olson AL; Dahi PB; Zheng J; Devlin SM; Lubin M; Gonzales AM; Giralt SA; Perales MA; Papadopoulos EB; Ponce DM; Young JW; Kernan NA; Scaradavou A; O'Reilly RJ; Small TN; Papanicolaou G; Barker JN
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):787-93. PubMed ID: 24548875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ito Y; Toyama K; Honda A; Nakazaki K; Arai S; Kurokawa M
    J Infect Chemother; 2020 Feb; 26(2):265-268. PubMed ID: 31421950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human Herpesvirus-6 Encephalitis in Allogeneic Hematopoietic Stem Cell Transplantation].
    Ogata M
    Brain Nerve; 2015 Jul; 67(7):919-30. PubMed ID: 26160819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
    Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
    Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.